A new era for treating high-risk neuroblastoma – research advances to look out for in 2024 24 Apr 2024 It's an exciting time for research into high-risk neuroblastoma. Over the past year, multiple trials testing new treatments showed promising results, and in 2024, new trials are expected to open to further advance this research. We look at some of the latest advances and how they could change the outlook for children with neuroblastoma. Find out more Show/Hide
Switching lab coats for formal wear – ICR scientists have “an amazing day” at Buckingham Palace 28 Mar 2024 The ICR was recently awarded a Queen’s Anniversary Prize in recognition of its transformational work in breast cancer research. Isy Godfrey spoke with two scientists who had recently attended the prize-giving ceremony at the Palace to learn more about their experience of the day and their work at the ICR. Find out more Show/Hide
Olaparib – a story of hope for cancer patients 11 Apr 2023 In 1995 researchers at The Institute of Cancer Research, London, uncovered the breast cancer susceptibility gene BRCA2. This discovery helped families to assess their cancer risk through genetic testing, enabling them to be closely monitored or take preventative measures. Find out more Show/Hide
Breaking down regulatory barriers could deliver step change improvements to prostate cancer outcomes 21 Mar 2023
ASCO 2021: The science behind olaparib’s promise shown in the OlympiA early breast cancer trial 04 Jun 2021